Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study

被引：0
|
作者：
Lushan Xiao
Yanxia Liao
Jiaren Wang
Qimei Li
Hongbo Zhu
Chang Hong
Ruining Li
Jingzhe He
Hao Cui
Hanzhi Dong
Lin Zeng
Li Liu
机构：
[1] Southern Medical University,Big Data Center, Nanfang Hospital
[2] Southern Medical University,Department of Infectious Diseases, Nanfang Hospital
[3] University of South China,Department of Medical Oncology, The First Affiliated Hospital, Hengyang Medical School
[4] Jiangxi Clinical Research Center for Cancer,Department of Medical Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Immune checkpoint inhibitors; Elderly; Primary liver cancer; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2299 / 2308
页数：9
相关论文
共 50 条
  • [21] Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)
    Orsini, D.
    Megna, M.
    Assorgi, C.
    Balato, A.
    Balestri, R.
    Bernardini, N.
    Bettacchi, A.
    Bianchelli, T.
    Bianchi, L.
    Buggiani, G.
    Burlando, M.
    Brunasso, A. M. G.
    Caldarola, G.
    Cameli, N.
    Campanati, A.
    Campione, E.
    Carugno, A.
    Chersi, K.
    Conti, A.
    Costanzo, A.
    Cozzani, E.
    Cuccia, A.
    D'Amico, D.
    Dal Bello, G.
    Dall'Olio, E. G.
    Dapavo, P.
    De Simone, C.
    Di Brizzi, E. V.
    Di Cesare, A.
    Dini, V.
    Esposito, M.
    Errichetti, E.
    Fargnoli, M. C.
    Fiorella, C. S.
    Foti, A.
    Fratton, Z.
    Gaiani, F. M.
    Gisondi, P.
    Giuffrida, R.
    Giunta, A.
    Guarneri, C.
    Legori, A.
    Loconsole, F.
    Malagoli, P.
    Narcisi, A.
    Paolinelli, M.
    Potestio, L.
    Prignano, F.
    Rech, G.
    Rossi, A.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [22] Efficacy and safety of immunotherapy in patients with liver metastases in patients with esophageal cancer: A retrospective, real-world study.
    Ren, Tiejun
    Wang, Dingyi
    Gu, Jinjin
    Zhao, Lijuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort study
    Colard-Thomas, J.
    Manceron, C.
    Duflos, C.
    Herman, F.
    Simon, M.
    Maria, A. T. J.
    Faillie, J. -L.
    Viala, M.
    Palassin, P.
    [J]. ESMO OPEN, 2023, 8 (06)
  • [24] Real-world safety and efficacy of immune-checkpoint inhibitors (ICIs) in the elderly NSCLC population of a UK tertiary centre
    Escola, Lopez Cristina
    Karim, Syed
    Sheikh, Omar
    Dring, Emma
    Mengoli, Kirsten
    Morrell, Lynnette
    Leighton, Sharon
    Adhikaree, Jason
    [J]. LUNG CANCER, 2021, 156 : S40 - S41
  • [25] Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort Study
    Raghavan, Arjun
    Goutam, Sid
    Musto, Grace
    Geirnaert, Marc
    Ye, Carrie
    O'Neil, Liam
    Graham, Jeffrey
    [J]. JOURNAL OF IMMUNOTHERAPY, 2024, 47 (01) : 1 - 6
  • [26] Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis
    Zhou, Chengjing
    Jiang, Ting
    Li, Rongzhen
    Yuan, Yan
    Xie, Weihao
    Huang, Xiaoxue
    Wang, Qiaoxuan
    Chang, Hui
    Chen, Gong
    Li, Yuhong
    Zeng, Zhifan
    Xiao, Weiwei
    Gao, Yuanhong
    [J]. CANCER COMMUNICATIONS, 2021, 41 (09) : 921 - 924
  • [27] The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study
    Iinuma, Koji
    Yamada, Toyohiro
    Kameyama, Koji
    Taniguchi, Tomoki
    Kawada, Kei
    Ishida, Takashi
    Nagai, Shingo
    Enomoto, Torai
    Ueda, Shota
    Takagi, Kimiaki
    Kawase, Makoto
    Takeuchi, Shinichi
    Kawase, Kota
    Kato, Daiki
    Takai, Manabu
    Nakane, Keita
    Koie, Takuya
    [J]. CANCERS, 2023, 15 (03)
  • [28] Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
    Ozgun, M. A.
    Dogan, I.
    Eryilmaz, M. Karakurt
    Erdogan, A. P.
    Ayhan, M.
    Hafizoglu, E.
    Tolunay, P. K.
    Cavdar, E.
    Cevik, G. T.
    Demir, H.
    Dulgar, O.
    Yilmaz, B.
    Cakir, E.
    Gokyer, A.
    Unal, O. U.
    Perkin, P.
    Sakalar, T.
    Gulmez, A.
    Tasci, E. S.
    Lacin, S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S892 - S892
  • [29] Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.
    Sevillano Fernandez, Elena
    Puente, Javier
    Vidal, Natalia
    Pinto, Alvaro
    Garcia Sanchez, Lourdes
    Fiorini, Aldo
    Chara Velarde, Luis Enrique
    Nalda Ariza, Irene
    Cassinello, Javier
    Rodriguez, Angel
    Galvan Ruiz, Saray
    Francisco Rodriguez-Moreno, Juan
    Barquin, Arantzazu
    Ruiz, Sergio
    Navarro, Paloma
    Yague, Monica
    Grande, Enrique
    Garcia-Donas, Jesus
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world
    Hao, Wen
    Liu, Wenjing
    Chang, Ruimin
    Yang, Mi
    Xin, Kai
    Liu, Jingxin
    Wang, Yibing
    Ren, Meijin
    Xie, Jiaqi
    Yang, Yang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (04)
12345